Thu, November 8, 2018

by: WOPRAI

David Coleman Upgraded (ADM) to Strong Buy on, Nov 8th, 2018

by: WOPRAI

Michael Yee Initiated (URGN) at Strong Buy and Held Target at $77 on, Nov 8th, 2018

by: WOPRAI

Katy Huberty Maintained (AAPL) at Buy with Increased Target to $63 on, Nov 8th, 2018

by: WOPRAI

Jonathan Lanterman Maintained (Z) at Hold with Decreased Target to $33 on, Nov 8th, 2018

by: WOPRAI

Jonathan Lanterman Maintained (ZG) at Hold with Decreased Target to $33 on, Nov 8th, 2018

by: WOPRAI

Dave Kang Maintained (AAOI) at Hold with Decreased Target to $19 on, Nov 8th, 2018

by: WOPRAI

Tavis McCourt Maintained (ALRM) at Strong Buy with Increased Target to $58 on, Nov 8th, 2018

Wed, November 7, 2018

by: WOPRAI

Oliver Chen Upgraded (TGT) to Buy and Held Target at $100 on, Nov 7th, 2018

by: WOPRAI

Raju Prasad Downgraded (BOLD) to Hold on, Nov 7th, 2018

by: WOPRAI

Tycho Peterson Downgraded (AXDX) to Hold and Decreased Target to $160 on, Nov 7th, 2018

by: WOPRAI

Dennis Coleman Upgraded (WES) to Strong Buy and Held Target at $51 on, Nov 7th, 2018

by: WOPRAI

Kevin Barker Upgraded (ZION) to Buy and Increased Target to $57 on, Nov 7th, 2018

by: WOPRAI

Shyam Patil Downgraded (ZG) to Sell and Held Target at $23 on, Nov 7th, 2018

by: WOPRAI

Shyam Patil Downgraded (Z) to Sell and Held Target at $23 on, Nov 7th, 2018

by: WOPRAI

TJ Schultz Upgraded (USAC) to Buy and Held Target at $21 on, Nov 7th, 2018

by: WOPRAI

Daniel Ford Maintained (AES) at Hold with Decreased Target to $14 on, Nov 7th, 2018

Tue, November 6, 2018

by: WOPRAI

David Toung Maintained (ABBV) at Strong Buy with Decreased Target to $115 on, Nov 6th, 2018

by: WOPRAI

Simeon Gutman Maintained (AAP) at Buy with Increased Target to $205 on, Nov 6th, 2018

by: WOPRAI

Ric Prentiss Maintained (USM) at Buy with Increased Target to $56 on, Nov 6th, 2018

by: WOPRAI

Nigel Dally Maintained (BHF) at Hold with Decreased Target to $55 on, Nov 6th, 2018

by: WOPRAI

Jeffrey Silber Maintained (BFAM) at Hold with Decreased Target to $120 on, Nov 6th, 2018

by: WOPRAI

Greg Badishkanian Maintained (BC) at Strong Buy with Decreased Target to $66 on, Nov 6th, 2018

by: WOPRAI

Geoffrey Kwan Maintained (BBU) at Buy with Decreased Target to $46 on, Nov 6th, 2018

by: WOPRAI

Brian Meredith Maintained (ALL) at Hold with Decreased Target to $100 on, Nov 6th, 2018

by: WOPRAI

Kevin Barker Upgraded (ZION) to Buy and Increased Target to $57 on, Nov 6th, 2018

by: WOPRAI

Simeon Gutman Maintained (AZO) at Hold with Increased Target to $800 on, Nov 6th, 2018

by: WOPRAI

Ben Herbert Maintained (CBOE) at Hold with Increased Target to $115 on, Nov 6th, 2018

by: WOPRAI

Paul Silverstein Upgraded (CALX) to Buy and Increased Target to $14 on, Nov 6th, 2018

by: WOPRAI

Kai Pan Maintained (AIG) at Buy with Decreased Target to $53 on, Nov 6th, 2018

by: WOPRAI

Brandon Folkes Maintained (ALKS) at Hold with Decreased Target to $41 on, Nov 6th, 2018

by: WOPRAI

Chris Olin Upgraded (ATI) to Strong Buy and Held Target at $34 on, Nov 6th, 2018

by: WOPRAI

Douglas Mitchelson Maintained (ATUS) at Buy with Increased Target to $23 on, Nov 6th, 2018

Mon, November 5, 2018

by: WOPRAI

Hans Chung Maintained (BABA) at Buy with Decreased Target to $203 on, Nov 5th, 2018

by: WOPRAI

David Lewis Maintained (BAX) at Sell with Decreased Target to $66 on, Nov 5th, 2018

by: WOPRAI

Joseph Spak Maintained (AXL) at Buy with Decreased Target to $16 on, Nov 5th, 2018

by: WOPRAI

John Murphy Upgraded (AXL) to Hold and Held Target at $13 on, Nov 5th, 2018

by: WOPRAI

Lloyd Walmsley Maintained (Z) at Hold with Decreased Target to $39 on, Nov 5th, 2018

by: WOPRAI

Lloyd Walmsley Maintained (ZG) at Hold with Decreased Target to $39 on, Nov 5th, 2018

by: WOPRAI

Dave Kang Maintained (AAOI) at Hold with Decreased Target to $22 on, Nov 5th, 2018

by: WOPRAI

Salveen Richter Initiated (ALLO) at Strong Buy and Held Target at $41 on, Nov 5th, 2018

by: WOPRAI

Bryan Kraft Maintained (AMCX) at Hold with Increased Target to $60 on, Nov 5th, 2018

by: WOPRAI

Joshua Pokrzywinski Maintained (AME) at Hold with Decreased Target to $81 on, Nov 5th, 2018

by: WOPRAI

David Risinger Upgraded (BHC) to Buy on, Nov 5th, 2018

by: WOPRAI

Alex Arfaei Maintained (ABBV) at Sell with Decreased Target to $71 on, Nov 5th, 2018

by: WOPRAI

George Bahamondes Maintained (ABR) at Hold with Increased Target to $12 on, Nov 5th, 2018

by: WOPRAI

Alethia Young Downgraded (ADVM) to Hold and Decreased Target to $40 on, Nov 5th, 2018

by: WOPRAI

David Nierengarten Maintained (ARGX) at Buy with Increased Target to $130 on, Nov 5th, 2018

by: WOPRAI

Ravi Shanker Maintained (ARCB) at Hold with Increased Target to $40 on, Nov 5th, 2018

Joel Beatty Maintained (SRPT) at Strong Buy with Increased Target to $188 on, Nov 6th, 2018

Joel Beatty of Citigroup, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Strong Buy with Increased Target from $174 to $188 on, Nov 6th, 2018.

Joel has made no other calls on SRPT in the last 4 months.



There are 2 other peers that have a rating on SRPT. Out of the 2 peers that are also analyzing SRPT, 0 agree with Joel's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Joel

  • Alethia Young of "Credit Suisse" Initiated at Buy and Held Target at $178 on, Thursday, September 6th, 2018
  • Matthew Harrison of "Morgan Stanley" Upgraded from Hold to Buy on, Wednesday, August 1st, 2018